Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, Concord Biotech has informed that the trading window for trading in the Equity Shares of the Company will be closed from 1st April, 2025 till the expiry of 48 hours after the declaration of the Audited Financial Results for the quarter and year ended on 31st March, 2025. Accordingly, all Designated Persons of the Company and their immediate relatives have been advised not to trade in the securities of the Company during the aforesaid Closure of Trading Window period. The company shall inform you in due course, the date of the Board Meeting at which the aforesaid Audited Financial Results for the quarter and year ended on 31st March, 2025 will be considered, approved and taken on record.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: